Cytokinetics (CYTK) Other Accumulated Expenses (2016 - 2024)
Historic Other Accumulated Expenses for Cytokinetics (CYTK) over the last 15 years, with Q3 2024 value amounting to $10.7 million.
- Cytokinetics' Other Accumulated Expenses fell 2221.74% to $10.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $10.7 million, marking a year-over-year decrease of 2221.74%. This contributed to the annual value of $10.6 million for FY2023, which is 6964.97% up from last year.
- Latest data reveals that Cytokinetics reported Other Accumulated Expenses of $10.7 million as of Q3 2024, which was down 2221.74% from $10.3 million recorded in Q2 2024.
- Cytokinetics' Other Accumulated Expenses' 5-year high stood at $14.8 million during Q1 2024, with a 5-year trough of $1.4 million in Q4 2020.
- Its 5-year average for Other Accumulated Expenses is $6.9 million, with a median of $6.2 million in 2022.
- Its Other Accumulated Expenses has fluctuated over the past 5 years, first soared by 29658.12% in 2021, then plummeted by 2221.74% in 2024.
- Quarter analysis of 5 years shows Cytokinetics' Other Accumulated Expenses stood at $1.4 million in 2020, then soared by 296.58% to $5.6 million in 2021, then grew by 11.78% to $6.2 million in 2022, then skyrocketed by 69.65% to $10.6 million in 2023, then rose by 1.19% to $10.7 million in 2024.
- Its Other Accumulated Expenses was $10.7 million in Q3 2024, compared to $10.3 million in Q2 2024 and $14.8 million in Q1 2024.